TickerFacts.

OSR Health, Inc. (OSRH): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.70M
As of 2025-12-31
$1.50M
As of 2026-06-30
+139.0%
3-year compound annual growth
2021-12-31: $4.8K2022-12-31: $124.5K2023-12-31: $15.4K2024-12-31: $341.5K2025-12-31: $1.70M$1.70M
2021-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.70M+397.8%2026-03-31, Balance as of period end
2024-12-31$341.5Kn/m2026-03-31, Balance as of period end
2023-12-31$15.4K-87.6%2025-04-22, Balance as of period end
2022-12-31$124.5Kn/m2024-04-17, Balance as of period end
2021-12-31$4.8Kn/a2023-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
OSR Health, Inc. (OSRH)2025-12-31$1.70M+397.8%
QHSLab, Inc. (USAQ)2025-12-31$636.2K+304.8%
Nuo Therapeutics, Inc. (AURX)2025-12-31$548.9K+93.5%
IceCure Medical Ltd. (ICCM)2025-12-31$8.90M+17.6%
Femasys Inc (FEMY)2025-12-31$9.27M+168.5%
Tenon Medical, Inc. (TNON)2025-12-31$3.76M-42.5%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$3.99M+291.4%
Vycor Medical Inc (VYCO)2025-12-31$87.0K-17.7%
Lucid Diagnostics Inc. (LUCD)2024-12-31$22.36M+18.3%

Compare OSRH, USAQ, AURX, ICCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗